XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the U.S. Food and Drug Administration (FDA) as peripheral crossing catheters. The catheters have been safely and successfully used to cross challenging lesions in both arterial chronic total occlusions (CTOs) and chronic obstructive venous lesions. The recent crossing FDA clearance adds to the previous clearances for endovascular support.
Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation (TAVI) system.
LivaNova PLC announced the publication of three separate studies highlighting the performance of its sutureless aortic valve, Perceval.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
DAIC Editor Dave Fornell takes a tour of some of the most interesting new artificial intelligence (AI) imaging ...
The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology Patient course in Washington on Jan. 25-27, 2019. The event brought together top experts in both cardiology and oncology to review new and relevant science in this rapidly evolving field.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap advanced cardiac imaging and mapping visualization system in persistent atrial fibrillation (AF) ablation procedures. Results presented at the 24th Annual AF Symposium, Jan. 24-26 in Boston, show the use of AcQMap resulted in 72.5 percent single-procedure freedom from AF at 12 months. Rigorous post-ablation monitoring showed 89.6 percent of the single-procedure patients experienced zero episodes of AF.
There are a few recent trends in X-ray angiography imaging systems that hospitals should be aware of if they are looking ...
Lenox Hill Hospital is the first hospital in New York City to successfully implant Abbott’s Tendyne transcatheter mitral valve replacement (TMVR) system to replace a leaky heart valve. The procedure was performed as part of a national clinical trial testing the safety and efficacy of the device as an alternative to invasive open heart surgery.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated with Philips’ Stellarex Drug-Coated Balloon (DCB) in above-the-knee (ATK) studies, which the company said reinforces the strong safety profile of Stellarex. The independent, third-party pooled analysis demonstrated low mortality rates through three years after the treatment with no device-related deaths.
DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displayed on the ...
The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
January 25, 2019 — Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad ...
January 25, 2019 — Profusa announced promising clinical data from two studies evaluating the company's Lumee Oxygen ...
Joe Cleveland, M.D., professor of cardiothoracic surgery, at the University of Colorado Hospital, offers a cardiac ...